Jan Rosenbaum

Jan Rosenbaum is the President and Chief Executive Officer at Kurome Therapeutics. She was engaged by CCHMC’s Innovation Ventures to establish value proposition and business case. She also has over 25 years Pharma, Biotech technical management experience. Jan was former CSO at Airway Therapeutics, 5 years in CincyTech and Advisory Panel at Harrington Discovery Institute.